MEDICO2022-10-012022-12-31 MEDICO2022-10-012022-12-31 MEDICO2022-10-012022-12-31in-bse-fin:OneOperatingExpenses01Member MEDICO2022-10-012022-12-31in-bse-fin:FourOperatingExpenses01Member MEDICO2022-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 540937 MEDICO NOTLISTED Medico Remedies Limited Equity 2022-04-01 2023-03-31 2023-02-10 2023-02-02 INR Lakhs Third quarter 14:00:00 17:15:00 2023-02-10 2023-02-10 Not applicable Single segment manufacturer and exporter of pharmaceutical formulations 2022-10-01 2022-12-31 Unaudited Standalone 388461000.00 8636000.00 397097000.00 259922000.00 25684000.00 -2472000.00 17178000.00 1996000.00 7370000.00 54267000.00 363945000.00 33152000.00 0.00 33152000.00 10600000.00 57000.00 10657000.00 0.00 22495000.00 0.00 0.00 0.00 0.00 22495000.00 -78000.00 22417000.00 0.00 0.00 16597000.00 10 1.36 1.36 0.00 0.00 1.36 1.36 0.00 0.00 0.00 Notes to Financial Results 1. The Company was listed in SME segment of BSE Ltd. as on 31st March, 2022 and migrated to the Main Board on 26th May 2022. Accordingly, the Company has adopted Indian Accounting Standard ( Ind AS ), as notified under section 133 of the Companies Act, 2013 ( the Act ) which is applicable to the Company from 1st April, 2022. 2. The Company has first time adopted Indian Accounting Standards ( Ind AS ) from 1st April, 2022 and accordingly these results have been prepared in accordance with the recognition and measurement principles laid down in the Ind AS 34, Interim Financial Reporting prescribed under section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder and other accounting pronouncements generally accepted in India. 3. The Company has adopted first time Indian Accounting Standard ( Ind AS ), accordingly the Company had prepared comparative figures of quarter & nine months ended 31st December, 2021 as given above by the management after exercising necessary due diligence to ensure financial results reflects true and fair view of Company's affairs in Indian Accounting Standards ( IndAS ). 4. The Company's management, pursuant to Ind AS 108 - Operating Segments, has concluded that the Company has only one reportable segment i.e. Pharmaceuticals . Accordingly, no separate disclosures of segment information have been made. 5. IGAAP and IND-AS Reconciliation: EQUITY RECONCILIATION F igures +/Dr & (-)/Cr Particulars 31.03.2021 FY 2021-22 FY 2022-23 (Q1) FY 2022-23 (Q2) FY 2022-23 (Q3) Reserves as per IGAAP 12,49,91,114 12,49,91,114 17,38,81,118 17,77,90,675 20,31,57,668 Provision of ECL adjusted in Opening Equity / Opening IndAS Adj (63,65,151) (63,65,151) (71,35,278) (74,65,004) (41,49,782) Ind AS Adjustments for the period (7,70,127) (3,29,726) 33,15,221 (1,58,659) Total Ind AS impact (63,65,151) (71,35,278) (74,65,004) (41,49,782) (43,08,441) Profit as per IGAAP 4,88,90,004 39,09,557 2,53,66,993 2,25,75,787 Reserves as per IndAS 11,86,25,963 16,67,45,840 17,03,25,671 19,90,07,886 22,14,25,014 OTHER EQUITY (SOCI) Reserve and Surplus Other items of Other Comprehensive Total Equity Particulars Securities Premium Reserve Retained Earnings Balance at April 1, 2022 3,33,16,388 16,67,45,840 -2,84,318 19,97,77,910 - Profit for the year - 35,79,831 - 35,79,831 Total comprehensive income for the period - - (71,080) (71,080) - Balance at June 30, 2022 3,33,16,388 17,03,25,671 (3,55,398) 20,32,86,661 - - - Profit for the year - 2,86,82,214 - 2,86,82,214 Total comprehensive income for the period - - (78,188) (78,188) Balance at Sep 30, 2022 3,33,16,388 19,90,07,886 (4,33,585) 23,18,90,688 Profit for the year - 2,24,95,315 - 2,24,95,315 Total comprehensive income for the period - - (78,187) (78,187) Balance at Dec 31, 2022 3,33,16,388 22,15,03,200 (5,11,772) 25,43,07,816 6. The Audit Committee has reviewed, and the Board of Directors has approved the above results and its release at their respective meetings held on 10th February, 2023. The Statutory Auditors of the Company have carried out Limited Review of the aforesaid results. Single segment 2022-04-01 2022-12-31 Unaudited Standalone 1124459000.00 40096000.00 1164555000.00 794026000.00 55731000.00 -4015000.00 44141000.00 5410000.00 19945000.00 171060000.00 1086298000.00 78257000.00 0.00 78257000.00 20572000.00 2928000.00 23500000.00 0.00 54757000.00 0.00 0.00 0.00 0.00 54757000.00 -227000.00 54530000.00 0.00 0.00 16597000.00 10 3.30 3.30 0.00 0.00 3.30 3.30 0.00 0.00 0.00 Other Expenses 54267000.00 Other Expenses 171060000.00 78000.00 227000.00 0.00 0.00